Our Work
Latham & Watkins Advises on Scientia Vascular’s US$30 Million Growth Facility
July 2, 2025
Firm represents leader in neurovascular innovation in the transaction.
Scientia Vascular, a leader in neurovascular innovation, has obtained a US$30 million term loan facility. The proceeds from the facility will be used to refinance Scientia’s existing credit facility and provide additional working capital, supporting continued growth for the company.
Latham & Watkins advised Scientia in the transaction with a finance team led by partners Elizabeth Oh and Haim Zaltzman, with associate Will Lane; and a corporate deal team led by partners Hans Brigham and Julie Scallen, with associate Laki Triantafylidis.